Spur Therapeutics
Toward the next generation of gene therapy.
122 employees · est. 2015 · Stevenage, United Kingdom
Helixmith
Regenerative Medicine for Neuropathic, Neuromuscular and Neuroischemic Diseases Using a Gene Therapy Approach
34 employees · est. 1996 · Seoul, Korea South
Helixmith is the older company (2015 vs 1996); Spur Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Spur Therapeutics | Helixmith |
|---|---|---|
| Founded | ||
| Founded | 2015 | 1996 older |
| Headquarters | ||
| Headquarters | Stevenage, United Kingdom | Seoul, Korea South |
| Employees | ||
| Employees | 122 larger | 34 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Not tracked yet |
| Total Funding | ||
| Total Funding | $260.50M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 7 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Gene Therapy, Liver-directed, Inherited Diseases, Clinical Trials, AAV-based Therapy, Hemophilia B, Fabry Disease, Gaucher Disease, Haemophilia A, Innovation, Global Locations, Systemic Diseases, United Kingdom, United States | Gene Therapy, Biopharmaceuticals, CAR-T Therapy, AAV Vector Therapy, Plasmid DNA Therapy, Neuromuscular Diseases, Diabetic Foot Ulcers, Amyotrophic Lateral Sclerosis, Coronary Artery Disease, Regenerative Medicine, Clinical Development, San Diego, KOSDAQ, Biotech, Innovative Therapies |
| Website | ||
| Website | spurtherapeutics.com | helixmith.com |
About Spur Therapeutics
Freeline is a biopharmaceutical company focused on developing liver-directed gene therapies for inherited systemic diseases. With clinical programs for Hemophilia B and Fabry disease, and preclinical programs in Gaucher disease and haemophilia A, the company aims to revolutionize treatment options f...
About Helixmith
Helixmith is a gene therapy company headquartered in Seoul, Korea, developing innovative biopharmaceuticals for previously untreated diseases and is listed on KOSDAQ. The company has an extensive gene therapy pipeline, including a CAR-T program targeting several different types of solid tumors and a...
We will tell you when either one moves
BounceWatch watches Spur Therapeutics and Helixmith for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Spur Therapeutics and Helixmith — by email.
Frequently Asked Questions
Compare Spur Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Spur Therapeutics on 11 Sep 2024, and Helixmith on 13 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.